AnALPK3truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
Preprint
Leinhos L. et al, (2024)
An autosomal dominant cardiac arrhythmia syndrome, ST Depression Syndrome, is caused by thede novocreation of a cardiomyocyte enhancer
Preprint
de Villiers CP. et al, (2024)
Flow inefficiencies in non-obstructive HCM revealed by left ventricular kinetic energy and hemodynamic force analysis from 4D flow CMR
Journal article
Pola K. et al, (2024), European Heart Journal - Imaging Methods and Practice
Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project.
Journal article
Ormondroyd E. et al, (2024), Eur J Hum Genet
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Journal article
Coats CJ. et al, (2024), Journal of the American Heart Association
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.
Journal article
Siontis KC. et al, (2024), Eur Heart J Digit Health, 5, 416 - 426
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome.
Journal article
Ni M. et al, (2024), JAMA
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal article
Maron MS. et al, (2024), N Engl J Med, 390, 1849 - 1861
Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits.
Journal article
Keaton JM. et al, (2024), Nat Genet
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
Journal article
Coleman JA. et al, (2024), Cardiovasc Res
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Journal article
Maron MS. et al, (2024), J Am Coll Cardiol
Metabolic profiling of aortic stenosis and hypertrophic cardiomyopathy identifies mechanistic contrasts in substrate utilization
Journal article
Pal N. et al, (2024), FASEB Journal, 38
Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans.
Journal article
Hayesmoore JBG. et al, (2024), Circ Genom Precis Med
Etiology and Phenotypes of Cardiomyopathy in Southern Africa: The IMHOTEP Multicenter Pilot Study
Journal article
Kraus SM. et al, (2024), JACC: Advances
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design.
Journal article
Coats CJ. et al, (2024), JACC Heart Fail, 12, 199 - 215
Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy.
Journal article
Curran L. et al, (2023), Circ Genom Precis Med
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Journal article
Pagnamenta AT. et al, (2023), Genome Med, 15
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
Journal article
McGurk KA. et al, (2023), Am J Hum Genet, 110, 1482 - 1495
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.
Journal article
Lagou V. et al, (2023), Nat Genet, 55, 1448 - 1461
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3.
Journal article
Owens AT. et al, (2023), J Card Fail